
Stages
Headquarters
US
Check Size
$0.5M β $10.0M
Investment Focus
Life Sciences Tools, Diagnostics, Therapeutics, Digital Health, Sustainability, Single cell analysis, Spatial biology, Multi-omic profiling, Synthetic biology, Molecular characterization, Infectious disease diagnostics, Cell free DNA, RNA and protein analysis, Pediatric genomics, Point of care solutions, Cell and gene therapies, Gene editing platforms, AI-enabled drug discovery, Nonviral delivery systems, Therapeutic protein libraries, Virtual care delivery, Patient engagement and care navigation, AI/ML enabled clinical care innovation, Agricultural biotechnology, Biomanufacturing, Bioremediation, Bioexploration
Illumina Ventures is a venture capital firm focused on investing in early-stage companies in the genomics and precision health sectors. They aim to build an ecosystem and translate investment into innovation, accelerating the impact on human health. The firm leverages its domain expertise, operating experience, and strategic relationship with Illumina (NASDAQ: ILMN) to identify and build companies that will transform healthcare. Illumina Ventures operates as true partners to entrepreneurs, supporting the development of breakthrough science and technology into market-leading companies. Through Illumina Ventures Labs, they accelerate value creation for early-stage genomics start-ups by providing access to capital, sequencing, mentorship, and fully equipped genomics lab capabilities.
Track your relationship with Illumina Ventures and manage next steps in your fundraising CRM.
Use GRID's AI-powered VC matcher to find investors that are the best fit for your startup based on sector, stage, geography, and more.
Get AI-Powered Matching Back to DirectoryAbhijit 'Ron' Mazumder, Ph.D.
Partner
Abhijit "Ron" Mazumder, Ph.D.
Partner
Abhijit βRonβ Mazumder, Ph.D.
Partner
Charles Lin, Ph.D.
Partner
Charles White, Ph.D.
Partner
David C. Duffy, Ph.D.
Partner
David R. Walt, Ph.D.
Partner
Donal Delaney
Partner
Fred Craves, Ph.D.
Partner
Ivan Coulter, Ph.D.
Partner
Mara Aspinall
Partner
Nick Naclerio, Ph.D.
Founding Partner
Ronan Byrne
Venture Advisor
Tom Willis, Ph.D.
Venture Partner
William Byrne, Ph.D.
Senior Associate
Wouter Meuleman, Ph.D.
Partner
Yuling Luo, Ph.D.
Venture Partner
Arnaud Autret
Board Member
Bill Rastetter, Ph.D.
Advisor
Jerry Steiner
Advisor